Arcadia Biosciences (NASDAQ:RKDA) Stock Passes Below 50-Day Moving Average – Here’s Why

Shares of Arcadia Biosciences, Inc. (NASDAQ:RKDAGet Free Report) passed below its fifty day moving average during trading on Wednesday . The stock has a fifty day moving average of $2.24 and traded as low as $1.8239. Arcadia Biosciences shares last traded at $1.95, with a volume of 15,134 shares changing hands.

Analyst Ratings Changes

Separately, Weiss Ratings reiterated a “sell (d-)” rating on shares of Arcadia Biosciences in a research note on Monday, December 29th. One investment analyst has rated the stock with a Sell rating, Based on data from MarketBeat.com, the company currently has a consensus rating of “Sell”.

Read Our Latest Stock Analysis on RKDA

Arcadia Biosciences Stock Performance

The firm has a market cap of $3.37 million, a P/E ratio of 0.77 and a beta of 0.60. The firm has a fifty day moving average of $2.24 and a 200-day moving average of $3.25.

Arcadia Biosciences Company Profile

(Get Free Report)

Arcadia Biosciences, Inc, founded in 2002 and headquartered in Davis, California, is an agricultural biotechnology company dedicated to developing crops and food ingredients that promote health and sustainability. By harnessing advanced genomics and precision‐breeding technologies, Arcadia creates proprietary trait platforms designed to enhance crop performance, nutritional value, and resilience to environmental stressors. The company’s scientific expertise focuses on non-transgenic approaches, enabling the delivery of novel traits without introducing foreign DNA.

Arcadia’s operations span two main segments: Crop Traits and Food Ingredients.

See Also

Receive News & Ratings for Arcadia Biosciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Arcadia Biosciences and related companies with MarketBeat.com's FREE daily email newsletter.